Clinical Impact of Introduction of Mammography Screening in a Non-Screening Country

Perry N Broeders M de Wol C Törnberg S European guidelines for quality assurance in mammography screening. European Commission. Luxembourg, 2001; 1–367.

Duffy SW Tabar L Fagerberg G Gad A Grontoft O South MC Day NE Breast screening, prognostic factors and survival — Results from the Swedish two-county study. Br Cancer 1991;64:1133–1138.

Smart CR Byrne C Smith RA Garfinkel L Letton AH Dodd GD Beahrs OH Twenty-year follow-up of the breast cancers diagnosed during the Breast Cancer Detection Demonstration Project. CA Cancer J Clin 1997;47:134–149.

Miller BA Feuer EJ Hankey BF Recent incidence trends for breast cancer in women and the relevance of early detection: An update. CA Cancer J Clin 1993; 43:27–41.

Day NE Williams DRR Khaw KT Breast cancer screening programmes: The development of a monitoring and evaluation system. Br J Cancer 1989; 59:954–958.

Moody C Corder A Mullee MA Guyer P Rubin C Cross M Royle GT Taylor I The impact of the first 3 years of breast cancer screening on the overall presentation of breast cancer. J R Soc Med 1994;87:259–262.

Rickard M Diagnosis of small sized invasive breast cancer by an Australian mammography screening service: Surrogate end-points for mortality reduction. Aust N Z J Surg 1998;68:415–8.

Kerlikowske K Efficacy of screening mammography among women aged 40 to 49 years and 50 to 69 years: Comparison of relative and absolute benefit. J Natl Cancer Inst Monogr 1997; 79–86.

Rostgaard K Holst H Mouridsen HT Lynge E Do clinical databases render population-based cancer registers obsolete? The example of breast cancer in Denmark. Cancer Causes Control 2000;11:669–674.

Copenhagen Mammography Screening Evaluation Group: Mammography screening for breast cancer in Copenhagen April 1991—March 1997. APMIS 1998; 106: 1–44.

Fracheboud J Nation-wide breast cancer screening in the Netherlands: Results of initial and subsequent screening 1990–1995). National evaluation team for breast cancer screening. Int J Cancer 1998; 75: 694–8.

Moss SM Results from the NHS breast screening programme 1990–1993). J Med Screen 1995; 2: 186–90.

Paci E Early indicators of efficacy of breast cancer screening programmes. Results of the Florence district programme. Int J Cancer 1990; 46: 198–202.

Doyle TC Clinical outcomes of the Otago-Southland breast cancer screening programme 1991). N Z Med J 1998; 111: 380–3.

Jørgensen T Mammografiscreening i Københavns Kommune. Ugeskr Læger 1996;158:1212–1216.

Hirsch FR Behandling af primær cancer mammae. Ugeskr Læger 1996;158:1218–1221.

Tange UB Hirsch FR Jensen MB Olsen AH Blichert-Toft M Rank FE Vejborg IM Mouridsen H Lynge E Mammographic screening in the county of Copenhagen. Clinical consequences of the first three screening rounds. Ugeskr Laeger 2002; 164: 1036–1040.

Tabar L Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am 1992;30:187–210.

Miller AB Baines CJ To T Wall C Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years. CMAJ 1992; 147: 1477–1488.

Autier P Shannoun F Scharpantgen A Lux C Back C Severi G Steil S Hansen-Koenig D A breast cancer screening programme operating in a liberal health care system: The Luxembourg Mammography Programme, 1992). Int Cancer 2002; 97: 828–832.

Tabar L Reduction in mortality from breast cancer after mass screening with mammography. randomised trial from the breast cancer screening working group of the Swedish national board of health and welfare. Lancet 1985; 1: 829–32.

Tabar L Duffy SW Krusemo UB Detection method, tumour size and node metastases in breast cancers diagnosed during a trial of breast cancer screening. Eur J Cancer Clin Oncol 1987;23:959–962.

Pamilo M Anttinen I Roiha M Kallio H Tallqvist G Soiva M Paloheimo J Kiviluoto H Suramo I Mammography screening for breast cancer: First year results from Helsinki and surroundings. Ann Med 1989;21:277–279.

Tabar L Update of the Swedish two-county trial of breast cancer screening: Histologic grade-specific and age-specific results. Swiss Surg 1999;5:199–204.

Ernst MF Voogd AC Coebergh JW Repelaer Van Driel OJ Roukema JA The introduction of mammographical screening has had little effect on the trend in breast-conserving surgery: A population-based study in Southeast Netherlands. Eur J Cancer 2001;37:2435–2440.

Farwell MF Foster RS Jr Costanza MC Breast cancer and earlier detection efforts. Realized and unrealized impact on stage. Arch Surg 1993; 128: 510–513.

Jamrozik K Byrne MJ Dewar JM Harvey JM Ingram DM Parsons RW Watson N The effect of mammographic screening on invasive breast cancer in Western Australia. Med J Aust 2000;172:203–206.

Olivotto IA Mates D Kan L Fung J Samant R Burhenne LJ Prognosis, treatment, and recurrence of breast cancer for women attending or not attending the Screening Mammography Program of British Columbia. Breast Cancer Res Treat 1999;54:73–81.

Borras JM Espinas JA Beemsterboer PM Granados A De Koning HJ Anticipating the consequences for the primary therapy of breast cancer after introducing screening. A more global picture for health care policy making. Int J Technol Assess Health Care 1998; 14: 268–276.

De Koning HJ Breast cancer screening: Its impact on clinical medicine. Br J Cancer 1990;61:292–7.

Ernster VL Barclay J Kerlikowske K Grady D Henderson C Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 1996;275:913–918.

de Koning HJ van Dongen JA van der Maas PJ Changes in use of breast-conserving therapy in years 1978–2000). Br J Cancer 1994; 70: 1165–1170.

Tange UB Hirsch FR Jensen MB Olsen AH Blichert-Toft M Rank FE Vejborg IM Mouridsen H Lynge E Mammography screening in the county of Copenhagen. Results of the first three screening rounds. Ugeskr Laeger 2002; 164: 1048–1052.

Ekeberg O Skjauff H Kåresen R Screening for breast cancer is associated with a low degree of psychological distress. Breast 2001;10:20–24.

Von Bulow B Psychological reactions connected to screening participation — Illustrated by breast cancer screening. Ugeskr Laeger 2002;164:165–167.

Von Bulow B Psychological consequences of breast cancer screening among healthy women. Ugeskr Laeger 2000;162:1053–1059.

Burman ML Taplin SH Herta DF Elmore JG Effect of false-positive mammograms on interval breast cancer screening in a health maintenance organization. Ann Intern Med 1999;131:1–6.

Boer R Warmerdam PG de Koning HJ van Oortmarssen GJ Extra incidence caused by mammographic screening. Lancet 1994;343:979–979.

Chu KC Smart CR Tarone RE Analysis of breast cancer mortality and stage distribution by age for the Health Insurance Plan clinical trial. J Natl Cancer Inst 1988;80:1125–1132.

Tabar L Significant reduction in advanced breast cancer. Results of the first seven years of mammography screening in Kopparberg, Sweden. Diagn Imaging Clin Med 1985; 54: 158–64.

Fagerberg G Baldetorp L Grontoft O Lundstrom B Manson JC Nordenskjold B Effects of repeated mammographic screening on breast cancer stage distribution. Results from a randomised study of 92 934 women in a Swedish county. Acta Radiol Oncol 1985; 24: 465–473.

Andersson I Mammographic screening and mortality from breast cancer: The Malmö mammographic screening trial. BMJ 1988;297:943–8.

Frisell J Glas U Hellstrom L Somell A Randomized mammographic screening for breast cancer in Stockholm. Breast Cancer Res Treat 1986;8:45–54.

Roberts MM Edinburgh trial of screening for breast cancer: Mortality at seven years. Lancet 1990;335:241–6.

Miller AB Baines CJ To T Wall C Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years. CMAJ 1992; 147: 1459–1476.

Shapiro S Evidence on screening for breast cancer from a randomized trial. Cancer 1977;39:2772–2782.

Collette C Collette HJ Fracheboud J Slotboom BJ De Waard F Evaluation of a breast cancer screening programme — The DOM project. Eur J Cancer 1992;28A:1985–1988.

Hakama M Aggressiveness of screen-detected breast cancers. Lancet 1995;345:221–4.

Peer PG Age-specific effectiveness of the Nijmegen population-based breast cancer-screening program: Assessment of early indicators of screening effectiveness. J Natl Cancer Inst 1994;86:436–41.

DBCG: DBCG — Danish Breast Cancer Cooperative Group. Reprint. Copenhagen, 1997.